CTRI/2025/08/092754尚未招募2/3 期
Randomised controlled clinical trial to evaluate the efficacy of Pippalyadi yoga in Kaphaja kasa in children.
Dr Rudresh Bhujaji Gawali1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2025年8月20日最近更新:
试验速览
- 阶段
- 2/3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 70
- 试验地点
- 1
- 主要终点
- The primary outcome focuses on the clinical efficacy of pippalyadi yoga in managing kaphaja kasa in children. It will be assessed based on symptomatic relief (frequency of bouts of cough, Nasal discharge, aruchi and Sputum) and objective parameter.
研究概览
简要总结
Cough is the 5th common for which patients seek care and prevalence rate of which is 25% in children worldwide. The traditional Indian medicine gives specific line of treatment and various remedies on kaphaja Kasa (productive cough) as prescribed in text. That’s why this subject for study has been chosen.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- None
入排标准
- 年龄范围
- 8.00 Year(s) 至 12.00 Year(s)（—）
- 性别
- All
入选标准
- •1.Productive cough associated with or without other symptoms described in the context of Kaphaja Kasa will be included. 2.Kaphajkasa less than 15 days duration will be selected. 3.Patients will be selected irrespective of sex, Caste between the age group of 8.
排除标准
- •1.All types of kasa except kaphajkasa.
- •2.Kasa as an anubandhalakshana in already diagnosed patients like Pneumonia, Emphysema, Asthma.
- •3.Age less than 8yrs and more than 12yrs.
结局指标
主要结局
The primary outcome focuses on the clinical efficacy of pippalyadi yoga in managing kaphaja kasa in children. It will be assessed based on symptomatic relief (frequency of bouts of cough, Nasal discharge, aruchi and Sputum) and objective parameter.
时间窗: 10 days treatment with 3 follow ups on 4th, 7th and 10 th day.
次要结局
- Pippalyadi churna is more effective than sitopaladi churna(Initial Assessment at 0 day)
研究者
Dr. Rudresh Bhujaji Gawali
late ledari redekar ayurvedic mahavidyala,Gadhinglaj,Kolhapur
研究点 (1)
Loading locations...
相似试验
招募中
2 期
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis2023-510249-79-00Boehringer Ingelheim International GmbH, Boehringer Ingelheim Espana S.A.100
尚未招募
不适用
COMPARATIVE CLINICAL STUDY TO REDUCE THE SYMPTOMS OF TAMAKA SHWASA IN CHILDREN WITH BHARANGI GUDA AND DRAKSHADI LEHA.CTRI/2026/02/105065Dr. Baishali Dani40
招募中
4 期
Trial of an AI-enabled Digital Stethoscope to Improve Antibiotic StewardshipNCT07362433Johns Hopkins University2,500
招募中
2 期
A multicenter, randomized, blinded, placebo controlled, phase II study to evaluate the safety and efficacy of cell therapy based with artificially expanded CD4+CD25+CD127- regulatory lymphocytes and anti-CD20 antibody in pediatric patients with presymptomatic diabetes type 1 (stage 1)2023-505226-33-00Poltreg S.A.150
Unknown
4 期
Bromelin, a Compound Prepared With Ananas Comocus Extract and Honey, for Acute CoughCough, AcuteNCT01356693Universidade Federal de Pernambuco102